Veko Care - Petmedin Tablets

The treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/or tricuspid valve regurgitation). The treatment of preclinical DCM in large breed dogs. When used in cases of preclinical DCM in large breed dogs, pimobendan significantly prolonged the time to the onset of CHF or sudden death, and also resulted in prolongation of the time to death due to all causes. If serious side effects or allergic reactions occur, stop giving Vetmedin and seek emergency veterinary medical attention.

Side effects A moderate positive chronotropic effect and vomiting may occur in rare cases. However, these effects are dose-dependent and can be avoided by reducing the dose in those cases. In rare cases transient diarrhoea, anorexia or lethargy have been observed.
Key Ingredients:

• Pimobendan 2.5 mg

Key Benefits:

• The treatment of dogs with evidence of increased heart size secondary to asymptomatic (preclinical) myxomatous mitral valve disease to delay the onset of clinical symptoms of heart failure, to reduce heart size and to increase survival time.

Directions For Use: 

• Dosage should be as prescribed by a veterinarian

Safety Information:

• Not for human use.
• For Animal Treatment Only.
• Store below 25°C.
• Keep Out of Reach of Children

Additional Information:

• Product Name: Veko Care - Petmedin Tablets
• Product Type: Calcium sensitiser and vasodilator (heart failure in dogs)
• Net Quantity: 30 tablet/box
• Shelf Life: 24 months
• Brand Name: Veko Care
• Name of packaging: Veko care
• Manufacturer and marketed by: Veko Care Pvt. Ltd., E-48 & 49, MIDC, Ranjangaon, Industrial Park, Dist-Pune. Maharashtra, India.
• Country of Origin: India